Decheng Capital LLC Legend Biotech Corp Transaction History
Decheng Capital LLC
- $326 Billion
- Q2 2024
A detailed history of Decheng Capital LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Decheng Capital LLC holds 98,558 shares of LEGN stock, worth $3.88 Million. This represents 1.34% of its overall portfolio holdings.
Number of Shares
98,558
Previous 86,363
14.12%
Holding current value
$3.88 Million
Previous $4.84 Billion
9.89%
% of portfolio
1.34%
Previous 0.65%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
216Shares Held
77.9MCall Options Held
412KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$452 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$295 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$261 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$225 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$198 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.59B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...